Exton, PA · Founded 2015 · Privately Held (backing)
Developer of a fibroblast based therepy designed to treat rare and serious genetic diseases. Castle Creek Biosciences is based in Exton, PA and was founded in 2015. It has raised $419 million across 4 recorded rounds; the latest was a $75 million later-stage round in Feb 2025.
PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$419.4M
Last round
Later Stage VC
Feb 2025
Cap table — not yet on record
Castle Creek Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Where does Castle Creek Biosciences's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Castle Creek Biosciences's 4 recorded funding rounds.